Five ways to fund AI. Only two create interest expense
Alphabet, AMD, Intel and CoreWeave raised $52.35bn for AI capacity in 22 days using five instruments. Where each lands on the statements is not the same.
In short
Between 27 July and 19 August 2026, Alphabet, Intel, AMD and CoreWeave raised $52.35bn for AI capacity. Core Scientific and NVIDIA moved capacity without paying cash at all.
- Means
- Five instruments: public bonds, a secured bank loan, common stock, warrants issued to a customer, and a guarantee of another firm's obligation. Only the first two create interest.
- Market
- Alphabet's 10-year coupon is 5.450%. CoreWeave pays Term SOFR plus 5.50%; its applicable benchmark fixing is unverified.
- Watch
- Guarantees land nowhere. NVIDIA backstopped up to $105bn of OpenAI leases and AMD agreed to cure a tenant's defaults. Neither appears in any debt or interest total.
In twenty-two days this summer, four companies raised $52.35 billion to build or equip AI capacity. Two others moved capacity without paying anything at all.
They used five different instruments. The money is interchangeable; where it lands on the financial statements is not.
How these were found
Not from news. We read the filing histories of twenty-one companies across the AI build-out and filtered by item number — the code that tells you what a Form 8-K is about before you open it.
| What we looked for | What it means |
|---|---|
| 8-K Item 1.01 | A material agreement was signed |
| 8-K Item 2.03 | A direct financial obligation was created — borrowed money |
| 8-K Item 3.02 | Unregistered securities were sold — equity |
| 424B2 / 424B5 / FWP | The final terms of a securities offering |
Twenty-one filings carried one of those markers between 15 July and 19 August. Four of them were false positives, and saying which matters as much as the list itself:
- Amazon’s 424B3 is the merger prospectus for its acquisition of Globalstar. Not a financing.
- Digital Realty’s and IREN’s 424B7s register resales by existing holders. Both documents say the company is not selling and will receive no proceeds.
- Equinix’s $5.5bn revolving facility is borrowing capacity. Nothing is owed and no interest accrues until it is drawn. Counting it would have inflated the total by more than a tenth.
The five instruments
New capital committed to AI capacity, 27 July – 19 August 2026
Alphabet public bonds, 9 tranches $25.00bn Intel common stock $20.00bn AMD senior notes $4.75bn CoreWeave secured term loan $2.60bn ───────── $52.35bn
Core Scientific warrants to its customer no cash NVIDIA guarantee of OpenAI leases up to $105bn contingent
Cash raised only. NVIDIA's figure is a contingent guarantee, not money raised, and is shown separately for that reason.
Only Alphabet, AMD and CoreWeave will report interest on any of this. That is $32.35bn of the $52.35bn — 61.8%. The rest arrives without an income-statement line.
The same dollar, priced three ways
Alphabet, AMD and CoreWeave all borrowed within eleven days of each other, for broadly the same purpose, and paid very different prices.
CoreWeave’s contractual margin is 5.50 percentage points above Term SOFR. Overnight SOFR is a different benchmark and cannot establish the loan’s all-in rate. The margin and a fixed bond coupon also differ in maturity, collateral and rate risk.
CoreWeave’s facility says more than its rate does. It is a delayed draw loan, available until December 2026 and maturing September 2031, secured on substantially all assets of the borrowing subsidiary, guaranteed by the parent, and subject to a debt service coverage ratio of at least 1.35x. Alphabet’s bonds carry none of that. The 8-K states the purpose plainly: to finance capital expenditure required to perform customer contracts, including GPU servers.
We have written up what Alphabet’s issue said through its maturity distribution and what AMD’s notes cost against its existing interest line separately.
The two that create no interest at all
Intel sold stock. 210,526,315 shares at $95.00, for gross proceeds of $20.0bn and $19.67bn before expenses. The last reported sale before pricing was $97.52, so the issue came at a 2.58% discount, with an option for a further 31.6m shares.
No interest, no maturity, no covenant. The cost is borne entirely by existing shareholders, and it does not appear on the income statement at all — it appears in the share count, which is the same mechanism that produced Intel’s $11.0bn quarterly loss earlier this year.
Core Scientific paid its customer in equity. On 27 July it leased 377 MW to AMD across three sites, plus 152 MW to a third-party operator, on fifteen-year terms with three five-year options. In connection with those leases it issued AMD a warrant for up to 30 million shares at $23.47, vesting at 12,222 shares per megawatt.
What vested on signing
AMD leases 377 MW Third-party operator leases 152 MW ─────── 529 MW × 12,222 shares/MW
= 6,465,438 shares vested immediately
From the Form 8-K. AMD holds a reservation right over a further 1,925 MW through 28 December 2028, which at the same rate would vest 23,527,350 shares — most of the 30 million authorised.
The landlord did not borrow and the tenant did not pay a premium. The capacity was bought with dilution.
The one that lands nowhere
On 17 August, NVIDIA guaranteed the residual value of leases for OpenAI, up to a cumulative $105 billion — a structure we took apart when it was filed. NVIDIA borrowed nothing. Until the guarantee is called, it exists in a footnote.
AMD did a smaller version of the same thing ten days earlier, and it is in the Core Scientific filing rather than AMD’s own. Under Credit Support Agreements covering the third-party operator’s 152 MW, AMD holds the right to cure that tenant’s defaults and takes on defined obligations if the tenant fails materially.
Two chipmakers, three weeks apart, both standing behind a customer’s real-estate obligations so the customer could take space. Neither commitment is debt. Neither generates interest. Neither would appear in any screen built on borrowings.
What our own numbers would have missed
Five days before this, we published a panel of interest expense across 1,519 companies. It is useful and it is led by Alphabet, whose interest line rose 514% — but run against this month, that panel would eventually capture Alphabet, AMD and CoreWeave and record nothing for Intel’s $20bn, nothing for Core Scientific’s warrant, and nothing for $105bn of guarantees.
That is not a flaw in the panel. Interest expense measures interest expense. It is a reminder that “how leveraged is the AI build-out” cannot be answered from a debt total, because a third of the cash this month and all of the contingent commitments were arranged so as not to become one.
What would make this wrong
- This is twenty-one companies, not the market. We chose them. A large financing by a company outside that list does not appear here, and there is no reason to think the list is complete.
- Twenty-two days is not a trend. Four raises in three weeks is a snapshot. It says these instruments were all in use at once; it does not establish a shift from one to another.
- CoreWeave’s rate floats and its loan is a commitment, not a balance. No all-in rate is calculated here. What it eventually pays depends on the applicable Term SOFR fixing and on how much it draws.
- The purposes are not all stated as AI. CoreWeave’s 8-K names GPU servers. Alphabet’s prospectus says general corporate purposes and we said so when we wrote about it. Intel’s use of proceeds is broader than data centres. We are grouping by timing and context, and that is a judgement.
- The $105bn is a ceiling, not an exposure. It is the cumulative maximum under the guarantee, and the guarantee extinguishes if OpenAI reaches a satisfactory credit rating.
- We did not read every exhibit. The credit agreements themselves run to hundreds of pages and are filed as exhibits. What is quoted here is from the 8-K narratives and the prospectus covers.
Check it yourself
The documents used here are linked below. For each named issuer, use SEC filing history to find the 8-K and prospectus documents in the stated window, then read the financing terms rather than treating an item-number match as proof of new borrowing. This is a comparison of the named transactions, not an exhaustive census of AI financing.
If a figure here does not match a filing, tell us and it will be corrected on the article and on the corrections log, with the date.
Calculations and inputs
Match the inputs to the source tables cited in the article, then apply the expressions below. Ratios are shown as decimals; multiply by 100 for a percentage. Results are rounded.
- Cash raised across the four issuers
25 + 4.75 + 2.6 + 20 ≈ 52.35- Share of that raised as debt
(25 + 4.75 + 2.6) / 52.35 ≈ 0.618- Intel's issue price against the prior close · INTC
95 / 97.52 - 1 ≈ -0.02584· ratio (×100 = %)- Intel gross proceeds · INTC
210526315 * 95 / 1e9 ≈ 19.999999925· $bn- Core Scientific warrant shares vested on signing · CORZ
(377 + 152) * 12222 ≈ 6465438· shares- Shares the AMD reservation right would vest in full · CORZ
1925 * 12222 ≈ 23527350· shares
Questions this answers
- How much did companies raise for AI data centres in August 2026?
- Across the filings reviewed here, four companies raised $52.35 billion in cash between 27 July and 19 August 2026: Alphabet $25.0bn of bonds, Intel $20.0bn of common stock, AMD $4.75bn of notes and CoreWeave a $2.6bn secured term loan. Separately, NVIDIA guaranteed up to $105bn of lease obligations that are not borrowings by NVIDIA.
- Why does the financing method matter if the money is the same?
- Because it determines where the cost appears. Borrowing creates interest expense on the income statement. Issuing stock dilutes existing holders and creates no interest. A guarantee of a third party's obligation creates neither until it is called, and appears only in the notes. An investor screening on debt or interest sees the first and misses the other two.
- What does CoreWeave pay compared with Alphabet?
- CoreWeave's August 2026 facility carries Term SOFR plus a 5.50% margin. The applicable Term SOFR fixing is not verified here, so no all-in rate is presented. CoreWeave's margin alone is approximately the size of Alphabet's entire coupon, and CoreWeave's loan is secured while Alphabet's is not.
- Is a revolving credit facility the same as raising money?
- No, and this screen excluded one for that reason. Equinix signed a $5.5bn revolving facility on 27 July 2026, but a revolver is borrowing capacity rather than borrowed money. Nothing is owed and no interest accrues until it is drawn. Counting undrawn commitments as capital raised would have overstated the total by more than 10%.
Corrections
Removed the 9.15% total loan rate and related comparisons. The agreement uses Term SOFR, not the overnight SOFR observation previously used. Only the verified contractual margin is presented.
Verify this yourself
5 sourcesThe links below identify the filings, structured data, and other sources used in this article. Market data is labeled separately. Calculated figures use the inputs and expressions explained in the article; a source link alone does not independently verify every calculation.
- Alphabet Inc — prospectus supplement, 6 August 2026 (424B5)Nine tranches, $25.0bn total, 4.500% 2028 through 6.500% 2066OPEN ↗
- Intel Corporation — prospectus supplement, 12 August 2026 (424B5)210,526,315 shares at $95.00 · gross $20.0bn · proceeds before expenses $19.67bnOPEN ↗
- CoreWeave, Inc — Form 8-K, 10 August 2026 (Items 1.01 and 2.03)$2.6bn delayed draw term loan · Term SOFR + 5.50% · matures 1 September 2031OPEN ↗
- Core Scientific, Inc — Form 8-K, 28 July 2026 (Items 3.02 and 7.01)Warrant to AMD for 30m shares at $23.47 · 529 MW leased · 12,222 shares vest per MWOPEN ↗
- Equinix, Inc — Form 8-K, 29 July 2026 (Items 1.01 and 2.03)$5.5bn revolving facility — excluded here as capacity rather than drawn borrowingOPEN ↗
Data as of Aug 25, 2026 · figures may be restated by the issuer after this date
Found a number that doesn't match the filing?Confirmed corrections are published on the corrections log, with the date and what changed.
This article is for informational purposes only and is not investment advice. Sources and data dates are listed below; reported figures may be restated later. Verify independently before making any investment decision.